FlexFactory™ Biomanufacturing Platform

FlexFactory is a bioprocess manufacturing platform that is transforming the way the biotechnology industry approaches drug production. Built almost exclusively around disposables technology, each unit operation within the FlexFactory is self-contained in its own controlled environment module (CEM), thereby eliminating the need for expensive clean-room facilities.

FlexFactory impacts biomanufacturing strategy in several fundamental ways:

Capital investment is reduced by 50% or more, largely due to the elimination of cleanroom facilities and CIP/SIP infrastructure.

Overall time to production is reduced by 70% or more (12-18 months vs. 3-5 years) due to simplified facilities, dual-track development, and Xcellerex's biomanufacturing services.

Major investments are delayed until much later in a drug's development cycle, after key risk milestones have passed.

Water consumption is reduced by 70%, and other operating expenses are reduced significantly.

Investments in FlexFactory can be easily leveraged for multi-drug production due to the platform's flexible, modular architecture.

FlexFactory operations can be physically TransPlanted from the Xcellerex biomanufacturing operation to the customer site and restarted almost immediately, further enhancing manufacturing flexibility.

FlexFactory is the only biomanufacturing platform that delivers the speed and capital efficiency of the CMO approach with the control and long-term economics of company-controlled manufacturing.